- Home
- CNTX vs PFO Comparison
CNTX vs PFO Comparison
Compare CNTX & PFO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- CNTX
- PFO
- Stock Information
- Founded
- CNTX 2015
- PFO 1991
- Country
- CNTX United States
- PFO United States
- Employees
- CNTX N/A
- PFO N/A
- Industry
- CNTX Biotechnology: Pharmaceutical Preparations
- PFO Finance Companies
- Sector
- CNTX Health Care
- PFO Finance
- Exchange
- CNTX Nasdaq
- PFO Nasdaq
- Market Cap
- CNTX 149.6M
- PFO 123.7M
- IPO Year
- CNTX 2021
- PFO N/A
- Fundamental
- Price
- CNTX $1.30
- PFO $9.03
- Analyst Decision
- CNTX Strong Buy
- PFO
- Analyst Count
- CNTX 3
- PFO 0
- Target Price
- CNTX $6.83
- PFO N/A
- AVG Volume (30 Days)
- CNTX 210.1K
- PFO 31.8K
- Earning Date
- CNTX 11-06-2024
- PFO 01-01-0001
- Dividend Yield
- CNTX N/A
- PFO 6.51%
- EPS Growth
- CNTX N/A
- PFO N/A
- EPS
- CNTX N/A
- PFO N/A
- Revenue
- CNTX N/A
- PFO N/A
- Revenue This Year
- CNTX N/A
- PFO N/A
- Revenue Next Year
- CNTX N/A
- PFO N/A
- P/E Ratio
- CNTX N/A
- PFO N/A
- Revenue Growth
- CNTX N/A
- PFO N/A
- 52 Week Low
- CNTX $0.77
- PFO $6.90
- 52 Week High
- CNTX $2.75
- PFO $8.51
- Technical
- Relative Strength Index (RSI)
- CNTX 25.94
- PFO 32.67
- Support Level
- CNTX $1.56
- PFO $9.05
- Resistance Level
- CNTX $2.32
- PFO $9.18
- Average True Range (ATR)
- CNTX 0.16
- PFO 0.11
- MACD
- CNTX -0.07
- PFO -0.02
- Stochastic Oscillator
- CNTX 17.88
- PFO 3.33
About CNTX Context Therapeutics Inc.
Context Therapeutics Inc is a clinical-stage biopharmaceutical company advancing medicines for solid tumors. The development team is advancing a pipeline of innovative therapies with a primary focus on treating female, hormone-dependent cancer, including breast, ovarian, and endometrial cancer. The company's preclinical program, CTIM-76, is an anti-Claudin 6 ("CLDN6") x anti-CD3 bispecific antibody ("bsAb") that is intended to redirect T-cell-mediated lysis toward malignant cells expressing CLDN6.
About PFO Flaherty & Crumrine Preferred and Income Opportunity Fund Incorporated
Flaherty & Crumrine Prfd Income Oppo is the United States-based diversified, closed-end investment company. Its primary investment objective is to produce high current income consistent with the preservation of capital. The fund invests in a diversified portfolio of preferred securities which includes traditional preferred stocks eligible for the inter-corporate dividends received a deduction and fully taxable preferred securities.